Table 1.

Impact of age and COVID-19 phase on contraception access

Predictor	Using contraception		Difficulty accessing contraception
	Adjusted odds ratio (95% CI)	P value	Adjusted odds ratio (95% CI)	P value
Age group, y
25–29	Reference		Reference
30–34	0.70 (0.47–1.02)	0.065	0.63 (0.25–1.58)	0.325
35–39	0.37 (0.26–0.53)	< 0.001	0.40 (0.18–0.89)	0.025
40–44	0.31 (0.22–0.44)	< 0.001	0.24 (0.10–0.59)	0.002
45–49	0.26 (0.18–0.38)	< 0.001	0.18 (0.06–0.52)	0.002
50–55	0.14 (0.08–0.22)	< 0.001	0.00 (0.00–0.00)	< 0.001
Phase
Pre-COVID	Reference		Reference
Phase 1	0.94 (0.90–0.98)	0.005	2.74 (1.54–4.88)	0.001
Phase 2	0.96 (0.90–1.02)	0.218	3.20 (1.66–6.18)	0.001
Phase 3	0.99 (0.90–1.08)	0.761	1.75 (0.68–4.48)	0.243
Phase 4	1.09 (0.96–1.24)	0.206	1.59 (0.59–4.27)	0.359
Phase 5	1.18 (1.02–1.36)	0.025	2.14 (0.89–5.15)	0.090